Quarterly report pursuant to Section 13 or 15(d)

Acquisition (Schedule of Assets and Liabilities Acquired) (Details)

v3.5.0.2
Acquisition (Schedule of Assets and Liabilities Acquired) (Details) - BiOptix [Member]
Sep. 12, 2016
USD ($)
Business Acquisition [Line Items]  
Cash and cash equivalents $ 17,000
Accounts receivable 21,000
Inventory 413,000
Prepaid and other assets 52,000
Equipment 93,000
Intangible rights acquired 2,312,000
Accounts payable (118,000)
Accrued and other liabilities (187,000)
Non-controlling interest (26,000)
Purchase price $ 2,577,000